Effectiveness of Teleretinal Imaging-Based Hospital Referral Compared With Universal Referral in Identifying Diabetic Retinopathy: A Cluster Randomized Clinical Trial

Sanil Joseph, Ramasamy Kim, Ravilla D Ravindran, Astrid E Fletcher, Thulasiraj D Ravilla, Sanil Joseph, Ramasamy Kim, Ravilla D Ravindran, Astrid E Fletcher, Thulasiraj D Ravilla

Abstract

Importance: Studies in high-income countries provide limited evidence from randomized clinical trials on the benefits of teleretinal screening to identify diabetic retinopathy (DR).

Objective: To evaluate the effectiveness of teleretinal-screening hospital referral (TR) compared with universal hospital referral (UR) in people with diabetes.

Design, setting, and participants: A cluster randomized clinical trial of 8 diabetes clinics within 10 km from Aravind Eye Hospital (AEH), Madurai, India, was conducted. Participants included 801 patients older than 50 years. The study was conducted from May 21, 2014, to February 7, 2015; data analysis was performed from March 12 to June 16, 2015.

Interventions: In the TR cohort, nonmydriatic, 3-field, 45° retinal images were remotely graded by a retinal specialist and patients with DR, probable DR, or ungradable images were referred to AEH for a retinal examination. In the UR cohort, all patients were referred for a retinal examination at AEH.

Main outcomes and measures: Hospital-diagnosed DR.

Results: Of the 801 participants, 401 were women (50.1%) (mean [SD] age, 60.0 [7.3] years); mean diabetes duration was 8.6 (6.6) years. In the TR cohort, 96 of 398 patients (24.1%) who underwent teleretinal imaging were referred with probable DR (53 [13.3%]) or nongradable images (43 [10.8%]). Hospital attendance at AEH was proportionately higher with TR (54 of 96 referred [56.3%]) compared with UR (150 of 400 referred [37.5%]). The intention-to-treat analysis based on all patients eligible for referral in each arm showed that proportionately more patients with TR (36 of 96 [37.5]%) were diagnosed with DR compared with UR (50 of 400 [12.5%]) (unadjusted risk ratio [RR], 3.00; 95% CI, 2.01-4.48). These results were little changed by inclusion of covariates (RR, 2.72; 95% CI, 1.90-3.91). The RR was lower in the per-protocol analysis based on all patients who adhered to referral (covariate-adjusted RR, 1.75; 95% CI, 1.12-2.74). Diagnoses of DR were predominantly mild or moderate nonproliferative DR (36 in TR and 43 in UR). In the UR arm, there were 4 cases of severe nonproliferative DR and 2 cases of proliferative DR. Age (RR, 0.98; 95% CI, 0.95-0.99), female sex (RR, 0.79; 95% CI, 0.64-0.98), and hypertension diagnosis (RR, 0.81; 95% CI, 0.68-0.95) were factors associated with lower attendance. Those with higher secondary educational level or more were twice as likely to attend (RR, 2.00; 95% CI, 1.32-3.03).

Conclusions and relevance: The proportionate yield of DR cases was higher in the TR arm, confirming the potential benefit, at least in the setting of eye hospitals in India, of a targeted referral approach using teleretinal screening to identify patients with DR.

Trial registration: ClinicalTrials.gov identifier: NCT02085681.

Conflict of interest statement

Conflict of Interest Disclosures: Mr Joseph received grant support from The Wellcome Trust, UK during the conduct of the study. No other disclosures were reported.

Figures

Figure.. Flowchart of Randomized Individuals
Figure.. Flowchart of Randomized Individuals
AEH indicates Aravind Eye Hospital; ITT, intention-to-treat; PP, per protocol.

References

    1. Anjana RM, Pradeepa R, Deepa M, et al. ; ICMR–INDIAB Collaborative Study Group . Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia. 2011;54(12):3022-3027. doi:10.1007/s00125-011-2291-5
    1. Recommendations on Prevention of Blindness from Diabetes Mellitus: report of a WHO consultation. Geneva, Switzerland: World Health Organization; 2005.
    1. Namperumalsamy P, Kim R, Vignesh TP, et al. . Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Br J Ophthalmol. 2009;93(4):429-434.
    1. Raman R, Rani PK, Reddi Rachepalle S, et al. . Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology. 2009;116(2):311-318. doi:10.1016/j.ophtha.2008.09.010
    1. Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med. 2009;55(2):92-96. doi:10.4103/0022-3859.48787
    1. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci. 2005;46(7):2328-2333. doi:10.1167/iovs.05-0019
    1. Sunita M, Singh AK, Rogye A, et al. . Prevalence of diabetic retinopathy in urban slums: the Aditya Jyot Diabetic Retinopathy in Urban Mumbai Slums Study—report 2. Ophthalmic Epidemiol. 2017;24(5):303-310. doi:10.1080/09286586.2017.1290258
    1. Jonas JB, Nangia V, Khare A, et al. . Prevalence and associated factors of diabetic retinopathy in rural central India. Diabetes Care. 2013;36(5):e69. doi:10.2337/dc12-2377
    1. Nadarajan B, Saya GK, Krishna RB, Lakshminarayanan S. Prevalence of diabetic retinopathy and its associated factors in a rural area of Villupuram District of Tamil Nadu, India. J Clin Diagn Res. 2017;11(7):LC23-LC26.
    1. Gadkari SS, Maskati QB, Nayak BK. Prevalence of diabetic retinopathy in India: the All India Ophthalmological Society Diabetic Retinopathy Eye Screening Study 2014. Indian J Ophthalmol. 2016;64(1):38-44. doi:10.4103/0301-4738.178144
    1. Namperumalsamy P, Nirmalan PK, Ramasamy K. Developing a screening program to detect sight-threatening diabetic retinopathy in South India. Diabetes Care. 2003;26(6):1831-1835. doi:10.2337/diacare.26.6.1831
    1. Raman R, Gella L, Srinivasan S, Sharma T. Diabetic retinopathy: an epidemic at home and around the world. Indian J Ophthalmol. 2016;64(1):69-75. doi:10.4103/0301-4738.178150
    1. Namperumalsamy P, Kim R, Kaliaperumal K, Sekar A, Karthika A, Nirmalan PK. A pilot study on awareness of diabetic retinopathy among non-medical persons in South India: the challenge for eye care programmes in the region. Indian J Ophthalmol. 2004;52(3):247-251.
    1. Gilbert CE, Babu RG, Gudlavalleti AS, et al. . Eye care infrastructure and human resources for managing diabetic retinopathy in India: The India 11-city 9-state study. Indian J Endocrinol Metab. 2016;20(suppl 1):S3-S10.
    1. Das T, Pappuru RR. Telemedicine in diabetic retinopathy: access to rural India. Indian J Ophthalmol. 2016;64(1):84-86. doi:10.4103/0301-4738.178151
    1. Mohan V, Prathiba V, Pradeepa R. Tele-diabetology to screen for diabetes and associated complications in rural India: The Chunampet Rural Diabetes Prevention Project Model. J Diabetes Sci Technol. 2014;8(2):256-261. doi:10.1177/1932296814525029
    1. Conlin PR, Fisch BM, Cavallerano AA, Cavallerano JD, Bursell S-E, Aiello LM. Nonmydriatic teleretinal imaging improves adherence to annual eye examinations in patients with diabetes. J Rehabil Res Dev. 2006;43(6):733-740. doi:10.1682/JRRD.2005.07.0117
    1. Crossland L, Askew D, Ware R, et al. . Diabetic retinopathy screening and monitoring of early stage disease in Australian general practice: tackling preventable blindness within a chronic care model. J Diabetes Res. 2016;2016:8405395. doi:10.1155/2016/8405395
    1. Davis RM, Fowler S, Bellis K, Pockl J, Al Pakalnis V, Woldorf A. Telemedicine improves eye examination rates in individuals with diabetes: a model for eye-care delivery in underserved communities. Diabetes Care. 2003;26(8):2476.
    1. Mansberger SL, Gleitsmann K, Gardiner S, et al. . Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: a randomized controlled trial. Telemed J E Health. 2013;19(12):942-948. doi:10.1089/tmj.2012.0313
    1. Mansberger SL, Sheppler C, Barker G, et al. . Long-term comparative effectiveness of telemedicine in providing diabetic retinopathy screening examinations: a randomized clinical trial. JAMA Ophthalmol. 2015;133(5):518-525. doi:10.1001/jamaophthalmol.2015.1
    1. World Medical Association World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194.
    1. American Telemedicine Association Practice guidelines & resources. . Accessed May 22, 2018.
    1. Wilkinson CP, Ferris FL III, Klein RE, et al. ; Global Diabetic Retinopathy Project Group . Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677-1682. doi:10.1016/S0161-6420(03)00475-5
    1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137-149. doi:10.1016/j.diabres.2013.11.002
    1. Srinivasan NK, John D, Rebekah G, Kujur ES, Paul P, John SS. Diabetes and diabetic retinopathy: knowledge, attitude, practice (KAP) among diabetic patients in a tertiary eye care centre. J Clin Diagn Res. 2017;11(7):NC01-NC07.
    1. Dey S, Nambiar D, Lakshmi JK, Sheikh K, Reddy KS Health of the elderly in India: challenges of access and affordability. . Published 2012. Accessed January 14, 2018.
    1. Raman R, Ganesan S, Pal SS, Gella L, Kulothungan V, Sharma T. Incidence and progression of diabetic retinopathy in urban India: Sankara Nethralaya—Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS II), report 1. Ophthalmic Epidemiol. 2017;24(5):294-302. doi:10.1080/09286586.2017.1290257
    1. Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260-277. doi:10.1111/ceo.12696
    1. Tozer K, Woodward MA, Newman-Casey PA. Telemedicine and diabetic retinopathy: review of published screening programs. J Endocrinol Diabetes. 2015;2(4):1-18. doi:10.15226/2374-6890/2/4/00131
    1. Liu SL, Mahon LW, Klar NS, et al. . A randomised trial of non-mydriatic ultra-wide field retinal imaging versus usual care to screen for diabetic eye disease: rationale and protocol for the Clearsight trial. BMJ Open. 2017;7(8):e015382. doi:10.1136/bmjopen-2016-015382
    1. Gosheva M, Klameth C, Norrenberg L, et al. . Quality and learning curve of handheld versus stand-alone non-mydriatic cameras. Clin Ophthalmol. 2017;11:1601-1606. doi:10.2147/OPTH.S140064
    1. Sengupta S, Sindal MD, Besirli CG, et al. . Screening for vision-threatening diabetic retinopathy in South India: comparing portable non-mydriatic and standard fundus cameras and clinical exam. Eye (Lond). 2018;32(2):375-383.
    1. Ryan ME, Rajalakshmi R, Prathiba V, et al. . Comparison Among Methods of Retinopathy Assessment (CAMRA) Study: smartphone, nonmydriatic, and mydriatic photography. Ophthalmology. 2015;122(10):2038-2043. doi:10.1016/j.ophtha.2015.06.011

Source: PubMed

3
Suscribir